salary overview

How is the salary and benefits at 北京振东光明药物研究院有限公司 ? Are the salaries high at ?Salary range: ¥2K-50K, with 64.3% of positions earning 10-20K, 本科 salary: ¥16.4K, 硕士: ¥24.2K.

salary range: 2K - 50K, where 64.3% of positions earn ¥10-20K

7.1% 2-3K ***  ? 10-15K ***  ? 15-20K 14.3% 20-30K 7.1% 30-50K 7.1% 50K以上

Note: the salary statistics for 北京振东光明药物研究院有限公司 are based on 14 salary records from the past year. The data depends on the position samples and is for reference only.

￥10-20K

64.3% of positions earn

Note: the average salary is analyzed based on job postings published by the company. We recommend reviewing it together with position type, education, region and experience.

salary changes over the years

￥9k 2021 ￥31.4k 2022 ￥37.9k 2023 ￥21k 2025

Note: the data depends on salary samples of online job postings in the corresponding years and does not fully represent the actual situation within the company. For reference only.

北京振东光明药物研究院有限公司Salary range: 2-3K: %, 20-30K: %, 30-50K: %, 50K以上: %. Salary changes over the years: Avg salary in 2025: ¥21K, Avg salary in 2023: ¥37.9K, Avg salary in 2022: ¥31.4K, Avg salary in 2021: ¥9K. . Disclaimer: statistics are based on job posting analysis and do not represent the actual situation of current employees; system stability may affect objectivity, so please treat the data as reference only. Data inaccurate? Report it

Manage

education requirements: 本科 is the most common

50% 本科 50% 硕士

What education does 北京振东光明药物研究院有限公司 require? 本科占比最多，占50%，硕士占50%

salary by education

Note: 北京振东光明药物研究院有限公司 salaries by education, 本科 positions earn ¥16.4K, for other education levels, click the detail page to view

Salaries for hot jobs of

Are salaries high at 北京振东光明药物研究院有限公司? We provide: ra, 临床, pm, qa, 分析, 制剂总监, 制剂研究, 医学专员. Click to view detailed salary analysis by job.

employee benefits

Add benefit

五险一金年终奖奖金提成

salary list/ranking

Position Region Salary↓ (posted by company)

Note: 北京振东光明药物研究院有限公司 employee salarydata is collected from public salary information published on various websites by the company in the past year. For reference only.